UNASSIGNED: An injectable, @entity3006 ( @entity3006 )-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs). Two approaches were examined both individually, and in combination, in order to achieve this goal. The first approach involved the encapsulation and release of @entity12017 ( @entity12017 ), a powerful mineralization stimulant. Results confirmed that the rapid gelation of the chitosan sponge prompted high encapsulation of @entity12017 and provided a controlled release over a period of 30days with no burst release. The second approach was aimed at encapsulating pyrophosphatase (PPtase) in the chitosan sponge to cleave @entity9955 ( @entity7371 ) - a mineralization inhibitor and a degradation by-product of the chitosan sponge - into @entity4613 ions (Pi). PPtase was successfully encapsulated in the chitosan sponge and was able to completely eliminate @entity7371 from the media by cleaving them to Pi. Chitosan sponges releasing Pi into the media were shown to increase overall biomineralization fourfold as compared to controls, an amount equivalent to biomineralization caused by direct injection of 1 g of free @entity12017 to the cells. Even though the combined encapsulation of 1 g @entity12017 and PPtase in the sponges did not demonstrate an additional increase in biomineralization, encapsulation of low concentrations of @entity12017 can promote mesenchymal stem cell migration into the sponge after application in vivo. The findings suggest that the sponge-PPtase system likely allows excellent bone regeneration with lower concentrations of @entity12017 , reducing risks and expense of the treatment. STATEMENT OF SIGNIFICANCE: There are bone defects, known as critical size defects, which do not heal on their own and require a therapeutic intervention. The current commercially-available therapies use large quantities of growth factors, such as Bone Morphogenetic Proteins (BMPs), which makes them expensive and a source for a myriad of unwanted side effects. In this manuscript we demonstrate, for the first time, the use of an injectable chitosan-based sponge that contains no inorganic components, but can nonetheless act as a source of @entity4613 ions to improve bone mineralization. We also demonstrate that this sponge can entrap small concentrations of @entity12017 and provide controlled release over time. The ability to release @entity4613 ions and low concentrations of @entity12017 makes this therapeutic intervention clinically-relevant, affordable, and safe.

A combinatorial approach towards achieving an injectable, self-contained, XXXX -releasing scaffold for promoting biomineralization in critical size bone defects.

@entity7371 :: ('CHEBI:60614', 'Chemical') :: ['PPi'] @entity4613 :: ('D010710', 'Chemical') :: ['phosphate'] @entity3006 :: ('MESH:D006153', 'Chemical') :: ["guanosine 5'-diphosphate", 'GDP'] @entity12017 :: ('655', 'Gene') :: ['Bone Morphogenetic Protein 7', 'BMP-7'] @entity9955 :: ('MESH:C107241', 'Chemical') :: ['pyrophosphate']
@entity4613 :: (D010710,Chemical) :: ['phosphate']
